SCHEMBL1609651

SCHEMBL1609651

Cc1ccc2c(c1)C(=O)c1cc(C)ccc1C2

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 4/20 0.71
ELANE P08246 1/20 0.54
MAOA P21397 2/20 0.50
MAOB P27338 1/20 0.50
ACHE P22303 1/20 0.50
PARP10 Q53GL7 2/20 0.48
PARP1 P09874 1/20 0.48
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA4 P22748 1/20 0.45
CA7 P43166 1/20 0.45
CA9 Q16790 1/20 0.45
ALDH1A1 P00352 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MEN1 O00255 1/20 0.42
MAPT P10636 1/20 0.42
KMT2A Q03164 1/20 0.42
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
ADORA1 P30542 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6056920 0.98 METAP1 (0.69) METAP1ELANEMAOAMAOBACHE
SCHEMBL6056983 0.96 METAP1 (0.67) METAP1ELANEMAOAMAOBACHE
SCHEMBL1611036 0.94 METAP1 (0.65) METAP1ELANEMAOAMAOBACHE
SCHEMBL6905059 0.90 MAOA (0.67) METAP1ELANEMAOAMAOBACHE
SCHEMBL1512741 0.87 METAP1 (0.67) METAP1ELANEMAOAMAOBACHE
SCHEMBL31124706 0.86 METAP1 (0.71) METAP1ELANEMAOAMAOBACHE
SCHEMBL11891506 0.86 METAP1 (0.71) METAP1ELANEMAOAMAOBACHE
SCHEMBL14925847 0.86 METAP1 (0.60) METAP1ELANEMAOAMAOBACHE
SCHEMBL10693161 0.86 METAP1 (0.64) METAP1MAOBACHEALDH1A1SMN1; SMN2
SCHEMBL17899376 0.86 MAOA (0.58) METAP1ELANEMAOAMAOBLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116635386-A Substituted pyridazinone herbicides FMC公司 2023-08-22 CN disclosed
US-9090819-B2 Organic electroluminescent element, display device, illuminating device and condensed polycyclic heterocyclic compound Konica Minolta, Inc. (JP) 2015-07-28 US disclosed
US-9090819-B2 Organic electroluminescent element, display device, illuminating device and condensed polycyclic heterocyclic compound Konica Minolta, Inc. (JP) 2015-07-28 US disclosed
US-20120085997-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, ILLUMINATING DEVICE AND CONDENSED POLYCYCLIC HETEROCYCLIC COMPOUND KONICA MINOLTA HOLDINGS, INC. (JP) 2012-04-12 US disclosed
US-20120085997-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, ILLUMINATING DEVICE AND CONDENSED POLYCYCLIC HETEROCYCLIC COMPOUND KONICA MINOLTA HOLDINGS, INC. (JP) 2012-04-12 US disclosed
US-4792551-A 9-anthryloxyaminoalkanes and related compounds as anti-inflammatory and analgetic agents SYNTEX (U.S.A.) INC. (US) 1988-12-20 US disclosed
EP-0132351-A2 9-Anthryloxyaminoalkanes and related compounds, processes for their preparation and pharmaceutical compositions containing them SYNTEX (U.S.A.) INC. (US) 1985-01-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120085997-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, ILLUMINATING DEVICE AND CONDENSED POLYCYCLIC HETEROCYCLIC COMPOUND CCNE2, C1S, SCO2 METAP1 2747/4885ELANE 1052/4885MAOA 824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.